<DOC>
	<DOCNO>NCT00648973</DOCNO>
	<brief_summary>The study determine drug work relieve nasal congestion experience people seasonal allergy .</brief_summary>
	<brief_title>To Determine Diphenhydramine Works Nasal Congestion Two Different Doses</brief_title>
	<detailed_description>Subjects meet inclusion/exclusion criterion enrol placebo run-in phase study Day -7 ( prerandomization , Visit 1 ) . Baseline symptom score establish run-in phase . Subjects moderate nasal congestion take least 80 % study medication run-in phase eligible enrollment two-week double-blind phase study randomize Day 1 ( randomization , Visit 2 ) . They treat two week assign medication . The severity signs/symptoms evaluate subject every morning night investigator visit Day 7 Day 14 . In addition , subject investigator provide global evaluation response treatment Day 7 Day 14 . Safety evaluate adverse event report study , vital sign , incidence somnolence .</detailed_description>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<criteria>otherwise healthy male females 12 65 year age hypersensitivity specific pollens minimum 2 year prior study start appropriate SAR sign/symptoms score pregnancy , lactation contraception issue contraindicate medication therapy evidence clinical , dietary , lifestyle psychiatric issue , opinion investigator , could increase risk subject research staff , interfere interpretation study result</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Seasonal Allergic Rhinitis , nasal congestion</keyword>
</DOC>